145 related articles for article (PubMed ID: 29537858)
21. Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials.
Russell JA; Lee T; Singer J; De Backer D; Annane D
J Crit Care; 2018 Oct; 47():333-337. PubMed ID: 29958734
[TBL] [Abstract][Full Text] [Related]
22. Physician Variation in Time to Antimicrobial Treatment for Septic Patients Presenting to the Emergency Department.
Peltan ID; Mitchell KH; Rudd KE; Mann BA; Carlbom DJ; Hough CL; Rea TD; Brown SM
Crit Care Med; 2017 Jun; 45(6):1011-1018. PubMed ID: 28426466
[TBL] [Abstract][Full Text] [Related]
23. The Relationship Between Norepinephrine Equivalent Dose of Vasopressors Within 24 Hours From the Onset of Septic Shock and In-Hospital Mortality Rate.
Sato R; Duggal A; Sacha GL; Rudoni MA; Yataco AC; Khanna AK; Dugar S
Chest; 2023 Jan; 163(1):148-151. PubMed ID: 35921884
[No Abstract] [Full Text] [Related]
24. Less is more: catecholamine-sparing strategies in septic shock.
Venkatesh B; Khanna AK; Cohen J
Intensive Care Med; 2019 Dec; 45(12):1810-1812. PubMed ID: 31520103
[No Abstract] [Full Text] [Related]
25. Treatment of hypotension in septic shock.
Pastor CM; Morel DR
Lancet; 1996 Mar; 347(9001):622; author reply 622-3. PubMed ID: 8596355
[No Abstract] [Full Text] [Related]
26. Vasopressor dosing in septic shock.
Alaniz C; Pollard S
Crit Care Med; 2013 Dec; 41(12):e483-4. PubMed ID: 24275412
[No Abstract] [Full Text] [Related]
27. Norepinephrine vs. dopamine: new recommendations for initial vasopressor selection in septic shock.
Bartel B
S D Med; 2014 May; 67(5):200-1. PubMed ID: 24851468
[No Abstract] [Full Text] [Related]
28. Norepinephrine administration in septic shock: how much is enough?
De Backer D; Vincent JL
Crit Care Med; 2002 Jun; 30(6):1398-9. PubMed ID: 12072710
[No Abstract] [Full Text] [Related]
29. Weapons of pressure resuscitation for septic shock.
Martin C
Intensive Care Med; 2003 Oct; 29(10):1621-2. PubMed ID: 12942169
[No Abstract] [Full Text] [Related]
30. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
[TBL] [Abstract][Full Text] [Related]
31. Dopamine therapy in septic shock: detrimental effect on survival?
Boulain T; Runge I; Bercault N; Benzekri-Lefevre D; Wolf M; Fleury C
J Crit Care; 2009 Dec; 24(4):575-82. PubMed ID: 19327324
[TBL] [Abstract][Full Text] [Related]
32. beta2-Adrenergic receptor gene polymorphism is associated with mortality in septic shock.
Nakada TA; Russell JA; Boyd JH; Aguirre-Hernandez R; Thain KR; Thair SA; Nakada E; McConechy M; Walley KR
Am J Respir Crit Care Med; 2010 Jan; 181(2):143-9. PubMed ID: 19850944
[TBL] [Abstract][Full Text] [Related]
33. Is vasopressin increasing or decreasing mortality in patients with septic shock?
Rehberg S; Ertmer C; Van Aken H; Westphal M
Surg Infect (Larchmt); 2008 Apr; 9(2):215 author reply 216. PubMed ID: 18426355
[No Abstract] [Full Text] [Related]
34. Thiamine in septic shock patients with alcohol use disorders: An observational pilot study.
Holmberg MJ; Moskowitz A; Patel PV; Grossestreuer AV; Uber A; Stankovic N; Andersen LW; Donnino MW
J Crit Care; 2018 Feb; 43():61-64. PubMed ID: 28850930
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
[TBL] [Abstract][Full Text] [Related]
36. Management of septic shock with a norepinephrine-based haemodynamic algorithm.
Hernandez G; Bruhn A; Romero C; Javier Larrondo F; De La Fuente R; Castillo L; Bugedo G
Resuscitation; 2005 Jul; 66(1):63-9. PubMed ID: 15993731
[TBL] [Abstract][Full Text] [Related]
37. Vasopressor weaning in patients with septic shock.
Arellano DL; Hanneman SK
Crit Care Nurs Clin North Am; 2014 Sep; 26(3):413-25. PubMed ID: 25169693
[TBL] [Abstract][Full Text] [Related]
38. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
Svoboda P; Scheer P; Kantorová I; Doubek J; Dudra J; Radvan M; Radvanova J
Hepatogastroenterology; 2012 Jun; 59(116):1043-7. PubMed ID: 22580654
[TBL] [Abstract][Full Text] [Related]
39. Norepinephrine in septic shock.
Hernández G; Teboul JL; Bakker J
Intensive Care Med; 2019 May; 45(5):687-689. PubMed ID: 30631902
[No Abstract] [Full Text] [Related]
40. High-dose vasopressin is not superior to norepinephrine in septic shock.
Klinzing S; Simon M; Reinhart K; Bredle DL; Meier-Hellmann A
Crit Care Med; 2003 Nov; 31(11):2646-50. PubMed ID: 14605537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
